← Research.Patient.info
Browse research by treatment
1,000 treatments and interventions are being studied right now — from new medicines to therapies, devices and lifestyle programmes.
- Placebo6511182
- Pembrolizumab104212
- Carboplatin67138
- Cisplatin55117
- Paclitaxel43107
- Dexamethasone4687
- Cyclophosphamide4084
- Durvalumab3081
- Gemcitabine4177
- Bevacizumab4473
- Nivolumab3073
- Docetaxel3270
- Atezolizumab2166
- Rituximab2566
- Pemetrexed2965
- Lenalidomide1958
- No intervention4958
- Capecitabine2551
- Oxaliplatin2751
- Doxorubicin2648
- prednisone2044
- Standard of Care2643
- Daratumumab2241
- MRI3340
- Nab-paclitaxel1839
- Questionnaires3439
- blood sample3038
- Fludarabine1837
- Venetoclax1937
- Biospecimen Collection1936
- Pomalidomide1735
- Magnetic Resonance Imaging2034
- Bortezomib1233
- Olaparib1233
- Fulvestrant1533
- Irinotecan1932
- Radiotherapy1431
- Etoposide1531
- Cetuximab2031
- enzalutamide1331
- Obinutuzumab1230
- Vincristine1430
- Leucovorin1930
- Tocilizumab1629
- Abemaciclib1128
- Questionnaire2628
- Letrozole1228
- Radiation Therapy1028
- Temozolomide1527
- Blood sampling2426
- Trastuzumab1226
- Computed Tomography1125
- Trastuzumab deruxtecan1525
- Ribociclib1424
- Palbociclib724
- Exercise1724
- Fluorouracil1223
- Usual Care1623
- Control1523
- Ruxolitinib922
- Everolimus1022
- Rilvegostomig1721
- Semaglutide721
- Epcoritamab421
- Quality-of-Life Assessment721
- Questionnaire Administration921
- Sacituzumab Tirumotecan1521
- Cabozantinib821
- Dostarlimab720
- Azacitidine820
- Acalabrutinib820
- Carfilzomib920
- Cytarabine919
- Lenvatinib519
- data collection1519
- ipilimumab919
- Inavolisib1018
- Exemestane818
- Risankizumab818
- Cemiplimab718
- 5-Fluorouracil1418
- Amivantamab818
- Pumitamig1818
- Teclistamab818
- Bendamustine918
- Laboratory Biomarker Analysis218
- Topotecan1017
- Osimertinib417
- Tirzepatide1017
- Baricitinib817
- Guselkumab516
- Chemotherapy916
- Anastrozole616
- Dupilumab616
- Upadacitinib716
- Prednisolone1016
- Tremelimumab516
- Observation1216
- Zanubrutinib616
- Methotrexate715
- Niraparib515
- Midazolam915
- Avelumab215
- Trametinib615
- Belzutifan615
- Rescue Medication1414
- abiraterone acetate414
- Blood Samples1214
- methylprednisolone614
- Sunitinib714
- Pirtobrutinib713
- The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.13
- The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.13
- Ibrutinib413
- Glofitamab613
- Talquetamab613
- Vinorelbine613
- KEYTRUDA 25 mg/mL concentrate for solution for infusion12
- Tamoxifen512
- Bimekizumab412
- Elranatamab912
- Apalutamide312
- control group1012
- Matching placebo712
- Mirikizumab812
- Ocrelizumab212
- Positron Emission Tomography812
- Deucravacitinib411
- Sonrotoclax711
- IMVT-1402811
- Capivasertib311
- METFORMIN311
- Volrustomig711
- Biopsy911
- Blood test1111
- Abiraterone611
- Biopsy Procedure511
- Entrectinib310
- Eribulin310
- Giredestrant310
- Iberdomide510
- Dacarbazine410
- Ifosfamide610
- Darolutamide610
- Tacrolimus510
- Orforglipron510
- Empagliflozin710
- Isatuximab610
- Pertuzumab410
- Placebo Administration410
- No Intervention: Observational Cohort1010
- Surgery610
- standard care710
- Observational810
- Enfortumab Vedotin310
- Dato-DXd510
- Belantamab mafodotin410
- Ustekinumab310
- Afimkibart69
- Nipocalimab69
- Adagrasib79
- Tucatinib39
- Anakinra69
- Sotorasib39
- Filgotinib59
- Selinexor9
- Panitumumab89
- Tezepelumab49
- Polatuzumab vedotin39
- Placebo oral tablet59
- Bone Scan79
- Alectinib39
- Virtual reality79
- Folfox89
- normal saline79
- Radiation59
- Sample collection99
- Tislelizumab69
- KarXT99
- Adalimumab39
- Retatrutide29
- Tarlatamab28
- Linvoseltamab88
- Encorafenib48
- Luspatercept48
- prednisone/prednisolone78
- Psilocybin58
- Pulmonary vein isolation78
- Mitapivat18
- IPTACOPAN38
- Alpelisib38
- efgartigimod PH20 SC48
- Ianalumab28
- not applicable, observational study88
- Rescue Medications58
- Saline68
- Odronextamab68
- Blinatumomab78
- Echocardiography Test68
- Multigated Acquisition Scan58
- SBRT48
- IMFINZI 50 mg/mL concentrate for solution for infusion.8
- Apixaban48
- Dasatinib38
- Cagrilintide28
- Ramucirumab38
- Hydrocortisone37
- Datopotamab deruxtecan17
- Binimetinib57
- Atogepant37
- Zanidatamab67
- Busulfan57
- Calderasib77
- Folinic acid47
- Inclisiran47
- Sonelokimab17
- LHRH Agonist17
- Standard of Care (SOC)57
- Sham (No Treatment)77
- Diet77
- Amlitelimab7
- Biological collection77
- Zimberelimab7
- Tulisokibart27
- The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. Full details will be added to the study record within 30 months after the trial has ended.7
- Stereotactic ablative radiotherapy37
- secukinumab17
- Cognitive assessment67
- Benralizumab37
- ADT17
- bariatric surgery67
- Blood sample collection77
- Cardiac MRI47
- Depemokimab47
- deucrictibant67
- Echocardiogram77
- Elotuzumab37
- Lumbar Puncture67
- MRI scan57
- PET-MRI67
- Platinum-based chemotherapy37
- rilzabrutinib47
- Sacituzumab Govitecan57
- Surovatamig77
- Teriflunomide17
- Trifluridine/tipiracil47
- NNC0487-011167
- Corticosteroids37
- Divarasib47
- Questionnaire and Physical Exam77
- Temozolomide (TMZ)57
- Lazertinib27
- Tiragolumab27
- Rivaroxaban47
- Lunsekimig56
- riliprubart46
- Dapagliflozin46
- Camizestrant46
- Frexalimab36
- FOLFIRI66
- Levoleucovorin36
- Maridebart Cafraglutide46
- Elecoglipron66
- Breath test56
- Exercise training66
- Sham46
- 5-fluorouracil (5-FU)66
- Amoxicillin26
- Dexmedetomidine56
- Inulin66
- Ipatasertib26
- Brenipatide66
- Placebo Control56
- Pembrolizumab (KEYTRUDA®)46
- APG77736
- Crizotinib26
- Belimumab46
- Telisotuzumab adizutecan46
- Vincristine Sulfate6
- Sparsentan46
- Sham Procedure26
- Sacituzumab Govitecan-hziy16
- PREHABILITATION56
- Lebrikizumab16
- JNJ-772421136
- Cetrelimab16
- Vinblastine46
- Domvanalimab6
- Vedolizumab56
- Sotatercept26
- Observational study66
- Etentamig46
- Non-interventional46
- Lutikizumab16
- XBD17366
- Venepuncture46
- Whey protein56
- AZD012066
- Ezabenlimab16
- Gemcitabine/Cisplatin16
- neuropsychological tests56
- Non-Interventional Study56
- Patritumab Deruxtecan46
- Pemetrexed+carboplatin16
- Routine care66
- Standard Treatment56
- Stereotactic Body Radiotherapy36
- Time-restricted eating66
- Transcranial Direct Current Stimulation56
- Trastuzumab emtansine16
- AZD139036
- Mosunetuzumab46
- Zanzalintinib56
- Placebo IV46
- Risdiplam56
- 5-FU16
- Saruparib36
- Azacitidine (AZA)56
- Remibrutinib26
- Aspirin46
- Bone Marrow Aspiration26
- Melphalan46
- Intensity-Modulated Radiation Therapy26
- Ceralasertib26
- Zilovertamab vedotin56
- Elacestrant45
- Revumenib35
- vicadrostat45
- Itraconazole45
- Photobiomodulation55
- Imatinib45
- Golcadomide25
- Androgen Deprivation Therapy (ADT)35
- Placebo Comparator45
- Nerandomilast35
- Emicizumab35
- Vemurafenib25
- AZD98335
- Brentuximab vedotin35
- Nivolumab + Relatlimab45
- Placebo capsule25
- Ravulizumab25
- Zongertinib35
- Botulinum toxin type A15
- Lecanemab5
- Relatlimab35
- 177Lu-PSMA-61725
- Cefazolin35
- Daraxonrasib55
- Radiofrequency ablation45
- Route of administration: oral use5
- Vehicle Cream45
- Mitomycin C25
- Magnetic resonance imaging (MRI)55
- Rosuvastatin45
- Dietary Intervention35
- Brachytherapy25
- BCG35
- Aerobic Exercise45
- Regorafenib25
- Standard Care (in control arm)45
- Quality of Life questionnaires35
- Placebo tablet35
- Percutaneous Coronary Intervention45
- Ifinatamab deruxtecan45
- Futibatinib35
- Exercise Intervention45
- barzolvolimab25
- Active Surveillance35
- Inebilizumab45
- Survodutide35
- Smartwatch45
- Pemetrexed/Cisplatin15
- Furmonertinib5
- Ketamine Hydrochloride45
- Colonoscopy55
- Bleomycin15
- Momelotinib55
- Pegcetacoplan25
- Anifrolumab45
- indocyanine green35
- interview45
- Liver biopsy45
- mycophenolate mofetil55
- Physiotherapy45
- radical prostatectomy15
- Saliva sample25
- Tebentafusp35
- Urine sample35
- Intismeran autogene25
- Ritlecitinib5
- Elritercept55
- Opevesostat55
- Placebo (matched to NNC0487-0111)45
- Supportive care measures35
- Obexelimab15
- Selumetinib15
- Capmatinib35
- Cobimetinib15
- Patient Observation25
- Stereotactic Body Radiation Therapy15
- Ultrasound35
- Bone Marrow Biopsy15
- Oleclumab15
- Norepinephrine55
- Mavacamten25
- KarX-EC55
- Felzartamab35
- Bosutinib24
- Remdesivir44
- Bleximenib34
- Claseprubart24
- Pegylated liposomal doxorubicin44
- Efanesoctocog alfa24
- Plozasiran Injection4
- CGT948644
- AZD530514
- AFLIBERCEPT14
- Anvumetostat4
- Conduction system pacing44
- golexanolone4
- Itepekimab (SAR440340)4
- Blood tests44
- SYT-51044
- Treatment as Usual (TAU)34
- Cabazitaxel34
- Waiting list34
- Colchicine34
- Icotrokinra34
- Prostate biopsy14
- Transthoracic Echocardiogram34
- visugromab (CTL-002)34
- Vosoritide24
- BHV-700024
- Azithromycin34
- CTx00124
- disitamab vedotin14
- Gemcitabine + carboplatin4
- Leucovorin Calcium4
- AZD090124
- Optimal Medical Therapy24
- Pegylated liposomal doxorubicin (PLD)34
- Pelabresib34
- Psilocybin 25 mg44
- Ranibizumab14
- Finerenone (Kerendia, BAY94-8862)34
- Hydroxyurea34
- T-DXd24
- Tafasitamab4
- Ivosidenib44
- transthoracic echocardiography44
- Pacritinib24
- Quality of life44
- Protein Supplement34
- DOR/ISL4
- RCT21004
- LY353703144
- Escitalopram34
- Catheter ablation24
- Belrestotug4
- Efgartigimod IV34
- Zasocitinib44
- Sodium Chloride24
- Transcranial Direct Current Stimulation (tDCS)44
- Transcranial Magnetic Stimulation24
- [177Lu]Lu-DOTA-TATE14
- Spirometry24
- Rapcabtagene autoleucel4
- Povetacicept24
- mezigdomide34
- lung ultrasound44
- Epoetin Alfa24
- Enoxaparin24
- ECG44
- INZ-7014
- Biofeedback training44
- Aortic valve replacement34
- Stereotactic Body Radiotherapy (SBRT)34
- Zolbetuximab24
- Tranexamic Acid44
- Standard of care treatment34
- Skin biopsy34
- Povorcitinib14
- Placebos44
- Ofatumumab24
- Nilotinib14
- Mitapivat-matching placebo4
- givinostat34
- Garadacimab4
- Fianlimab4
- Electrocardiogram34
- education34
- Blood collection34
- Bulevirtide14
- Axicabtagene Ciloleucel24
- ALXN222014
- blood draw34
- Dabrafenib24
- Datopotamab deruxtecan (Dato-DXd)44
- Electrical Impedance Tomography24
- glucose24
- Goserelin24
- Lutathera24
- Mepolizumab4
- No Interventions44
- Non invasive ventilation34
- Placebo semaglutide14
- Placebo supplement34
- Repetitive Transcranial Magnetic Stimulation (rTMS)44
- Nemolizumab14
- Idelalisib24
- Sacituzumab govitecan-hziy (SG)14
- Nirogacestat14
- Imlunestrant24
- Budigalimab24
- Pegaspargase14
- Nemtabrutinib34
- Paltusotine14
- Pembrolizumab (+) Berahyaluronidase alfa24
- Pembrolizumab/Quavonlimab4
- Placebo for Atogepant14
- RO72042394
- Rucaparib14
- Saline Nasal Spray44
- Satralizumab24
- TAR-2004
- Venetoclax (VEN)34
- [177Lu]Lu-NeoB24
- [68Ga]Ga-NeoB24
- Sorafenib4
- Selpercatinib4
- MEDI47364
- XEN110134
- AAA61734
- Belumosudil34
- BMS-98650444
- Chemotherapy drug44
- Cilta-cel4
- Daunorubicin34
- Dactinomycin24
- RPT90444
- OPDIVO 10 mg/mL concentrate for solution for infusion.4
- Monalizumab14
- Lurbinectedin14
- Tecentriq 1 200 mg concentrate for solution for infusion4
- Forxiga 10 mg film-coated tablets4
- Degarelix14
- Cemdisiran24
- ASTX72724
- Apremilast34
- YERVOY 5 mg/ml concentrate for solution for infusion, OPDIVO 10 mg/mL concentrate for solution for infusion.4
- Tepotinib14
- Tazemetostat14
- Sirolimus34
- Rapamune 1 mg/mL oral solution4
- Pozelimab24
- Vutrisiran23
- Radiprodil13
- Phesgo23
- Placebo matching Vicadrostat23
- Waitlist33
- Leniolisib3
- Telisotuzumab Vedotin13
- LP35213
- BGB-1141733
- Acalabrutinib (ACP-196)3
- CYB00323
- Trontinemab13
- Creatine Monohydrate33
- AloCelyvir3
- JNJ-7893480413
- ALXN18503
- Probiotic33
- Mocertatug rezetecan33
- G-CSF23
- Axatilimab13
- Fenebrutinib3
- Litifilimab13
- Fingolimod3
- 68Ga-FAPI-463
- Carboplatin-Paclitaxel23
- cediranib13
- Endocrine therapy13
- Best Available Therapy (BAT)3
- JNJ-8718940133
- Loncastuximab Tesirine13
- Bictegravir3
- palliative radiotherapy13
- Bimatoprost SR3
- Pasritamig33
- Biomarker analysis of blood samples33
- Quality of Life questionnaire23
- BMS-98627813
- Control (Standard treatment)23
- azenosertib, also known as ZN-c33
- Bepirovirsen3
- Caffeine33
- HYDROXYCHLOROQUINE23
- Intravascular lithotripsy23
- Pembrolizumab 200 mg3
Showing the top 600 of 1,000 matches — refine your search to narrow down.